Predictive/prognostic tumor biomarkers, tumor-host immune interactions to immunotherapeutic strategies, Immune-monitoring tools of novel immune-modulators and cancer antigen specific immune cells, Translational and precision medicine tools such as liquid biopsy as biomarkers of response, Immune checkpoint inhibitors and immune modulatory vaccines as therapeutic targets, Lung cancer, Gastric cancer, Triple-negative breast cancer, Head and Neck cancers
